Pharmaceuticals company Syncom Formulation (India) announced Q3FY26 results Revenue from operations: Rs 11,544.06 lakh against Rs 12,753.32 lakh during Q3FY25, change -9%. PBT: Rs 2,608.8 lakh against Rs 1,726.22 lakh during Q3FY25, change 51%. PAT: Rs 1,890.81 lakh against Rs 1,300.2 lakh during Q3FY25, change 45%. EPS: Rs 0.23 for Q3FY26. Result PDF